|
1.
|
2024/09
|
|
Evaluation of glomerular hemodynamic changes by sodium-glucose-transporter 2 inhibition in type 2 diabetic rats using in vivo imaging
|
|
2.
|
2024/06/28
|
|
Automated immunoassay of serum NY-ESO-1 and XAGE1 antibodies for predicting clinical benefit with immune checkpoint inhibitor (ICI) in advanced non-small cell lung cancer
|
|
3.
|
2024/05/20
|
|
Evaluating the associations between compliance with CKD guideline component metrics and renal outcomes.
|
|
4.
|
2024/05/08
|
|
Factors affecting the sodium-glucose cotransporter2 inhibitors-related initial decline in glomerular filtration rate
and its possible effect on kidney outcome in chronic kidneydisease with type 2 diabetes: The Japan Chronic Kidney Disease Database
|
|
5.
|
2024/04/11
|
|
Development of a prognostic risk score to predict early mortality in incident elderly Japanese hemodialysis patients.
|
|
6.
|
2024/03/13
|
|
Mathematical expansion and clinical application of chronic kidney disease stage as vector field
|
|
7.
|
2024/01/18
|
|
New marker for chronic kidney disease progression and mortality in medical-word virtual space.
|
|
8.
|
2024
|
|
Associations of vitamin D receptor activators and calcimimetics with falls and effect modifications by physical activity: A prospective cohort study on the Japan Dialysis Outcomes and Practice Patterns Study.
|
|
9.
|
2024
|
|
Author Correction: Effectiveness of DialBetesPlus, a self-management support system for diabetic kidney disease: Randomized controlled trial.
|
|
10.
|
2024
|
|
Clinical Outcomes in Patients with CKD and Rapid or Non-rapid eGFR Decline: A Report from the DISCOVER CKD Retrospective Cohort.
|
|
11.
|
2024
|
|
Current dialyzer classification in Japan and mortality risk in patients undergoing hemodialysis.
|
|
12.
|
2024
|
|
Effectiveness of DialBetesPlus, a self-management support system for diabetic kidney disease: Randomized controlled trial.
|
|
13.
|
2024
|
|
eGFR slope as a surrogate endpoint for end-stage kidney disease in patients with diabetes and eGFR30 mL/min/1.73 m2 in the J-DREAMS cohort.
|
|
14.
|
2024
|
|
Factors affecting the sodium-glucose cotransporter 2 inhibitors-related initial decline in glomerular filtration rate and its possible effect on kidney outcome in chronic kidney disease with type 2 diabetes: The Japan Chronic Kidney Disease Database.
|
|
15.
|
2024
|
|
Glucose-lowering treatment pathways of individuals with chronic kidney disease and type 2 diabetes according to the Kidney Disease: Improving Global Outcomes 2012 risk classification.
|
|
16.
|
2024
|
|
Hyperkalaemia-related reduction of RAASi treatment associates with more subsequent inpatient care.
|
|
17.
|
2024
|
|
Maintained renin-angiotensin-aldosterone system inhibitor therapy with sodium zirconium cyclosilicate following a hyperkalaemia episode: a multicountry cohort study.
|
|
18.
|
2024
|
|
Projecting the clinical burden of chronic kidney disease at the patient level (Inside CKD): a microsimulation modelling study.
|
|
19.
|
2023/12/20
|
|
Effect of decreased platelets on postoperative recurrence of chronic subdural hematoma.
|
|
20.
|
2023/07/19
|
|
eGFR slope as a surrogate endpoint for clinical study in early stage of chronic kidney disease: from The Japan Chronic Kidney Disease Database
|
|
21.
|
2023/06
|
|
The Impact of Potassium Binders on Mortality in Patients with Hyperkalemia: A Single-Center Study
|
|
22.
|
2023/01/13
|
|
Preoperative elevated eosinophils in peripheral blood predicts recurrence of chronic subdural hematoma after surgery.
|
|
23.
|
2023/01/11
|
|
Immune checkpoint therapy and response biomarkers in non-small-cell lung cancer: serum NY-ESO-1 and XAGE1 antibody as predictive and monitoring markers
|
|
24.
|
2023
|
|
Association of Four Types of Vascular Access Including Arterial Superficialization with Mortality in Maintenance Hemodialysis Patients: A Nationwide Cohort Study in Japan.
|
|
25.
|
2023
|
|
Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia.
|
|
26.
|
2023
|
|
Effect of overweight/obesity and metabolic syndrome on frailty in middle-aged and older Japanese adults.
|
|
27.
|
2023
|
|
Impact of chronic potassium binder treatment on the clinical outcomes in patients with hyperkalemia: Results of a nationwide hospital-based cohort study.
|
|
28.
|
2023
|
|
Machine-learning-based Web system for the prediction of chronic kidney disease progression and mortality.
|
|
29.
|
2023
|
|
Multimorbidity patterns in the working age population with the top 10% medical cost from exhaustive insurance claims data of Japan Health Insurance Association.
|
|
30.
|
2022/12
|
|
Nutritional Management in Elderly CKD Patients in Japan
|
|
31.
|
2022/11
|
|
Machine learning models for prediction of HF and CKD development in early-stage type 2 diabetes patients.
|
|
32.
|
2022/11
|
|
Machine Learning Models Predicting Cardiovascular and Renal Outcomes and Mortality in Patients with Hyperkalemia. Nutrients.
|
|
33.
|
2022/09/12
|
|
Changes in serum antibody titers after vaccination for COVID-19 and evaluation of post-vaccination health conditions
|
|
34.
|
2022/08/10
|
|
Retrospective study on changes in renal function by treatment with two types of herbal medicines
|
|
35.
|
2022/06
|
|
Low Adherence to Kidney Disease: Improving Global Outcomes 2012 CKD Clinical Practice Guidelines Despite Clear Evidence of Utility
|
|
36.
|
2022/06
|
|
Performance Status Modifies the Association Between Vitamin D Receptor Activator and Mortality or Fracture: A Prospective Cohort Study on the Japanese Society for Dialysis Therapy (JSDT) Renal Data Registry.
|
|
37.
|
2022/04/23
|
|
Number of Children and Risk of Cardiovascular Disease in Japanese Women: Findings from the Tohoku Medical Megabank
|
|
38.
|
2022/04/06
|
|
Evaluation of maxillary and mandibular growth patterns with cephalometric analysis based on cervical vertebral maturation: A Japanese cross-sectional study
|
|
39.
|
2022/04
|
|
Routinely measured cardiac troponin I and N-terminal pro-B-type natriuretic peptide as predictors of mortality in haemodialysis patients
|
|
40.
|
2021/05/11
|
|
Effect of zinc deficiency on chronic kidney disease progression and effect modification by hypoalbuminemia.
|
|
41.
|
2021/01/19
|
|
Cardiovascular and Renal Outcomes Associated With Hyperkalemia in Chronic Kidney Disease: A Hospital-Based Cohort Study.
|
|
42.
|
2021/01
|
|
Postoperative recurrence of chronic subdural hematoma is more frequent in patients with blood type A.
|
|
43.
|
2021
|
|
Association between anemia and mortality in hemodialysis patients is modified by the presence of diabetes.
|
|
44.
|
2021
|
|
High-performance dialyzers and mortality in maintenance hemodialysis patients
|
|
45.
|
2021
|
|
Methods and Nutritional Interventions to Improve the Nutritional Status of Dialysis Patients in JAPAN
|
|
46.
|
2021
|
|
Methods and rationale of the DISCOVER CKD global observational study
|
|
47.
|
2021
|
|
Postoperative recurrence of chronic subdural hematoma is more frequent in patients with blood type A.
|
|
48.
|
2021
|
|
The combination of malnutrition-inflammation and functional status limitations is associated with mortality in hemodialysis patients.
|
|
49.
|
2020/12
|
|
Optimal phase analysis of electrocardiogram-gated computed tomography angiography in patients with Stanford type A acute aortic dissection.
|
|
50.
|
2020/11/28
|
|
Increased plasma plasmin-alpha2-plasmin inhibitor complex levels correlate with postoperative rebleeding after endoscopic surgery for spontaneous intracerebral hemorrhage.
|
|
51.
|
2020/10/17
|
|
Clinical and Economic Burden of Hyperkalemia: A Nationwide Hospital-Based Cohort Study in Japan.
|
|
52.
|
2020/10/15
|
|
Prevalences of hyperuricemia and electrolyte abnormalities in patients with chronic kidney disease in Japan: A nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database (J-CKD-DB)
|
|
53.
|
2020/07/20
|
|
Prevalence of anemia in patients with chronic kidney disease in Japan: A nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database (J-CKD-DB).
|
|
54.
|
2020/05/29
|
|
Application of explainable ensemble artificial intelligence model to categorization of hemodialysis-patient and treatment using nationwide-real-world data in Japan.
|
|
55.
|
2020/01
|
|
Renoprotective effects of sodium-glucose cotransporter-2 inhibitors and underlying mechanisms.
|
|
56.
|
2020
|
|
2018 Kidney Disease: Improving Global Outcomes (KDIGO) Hepatitis C in Chronic Kidney Disease Guideline Implementation: Asia Summit Conference Report
|
|
57.
|
2020
|
|
Beta-2 microglobulin and all-cause mortality in the era of high-flux hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study.
|
|
58.
|
2020
|
|
J-CKD-DB: a nationwide multicentre electronic health record-based chronic kidney disease database in Japan
|
|
59.
|
2020
|
|
Postdialysis blood pressure is a better predictor of mortality than predialysis blood pressure in Japanese hemodialysis patients: the Japan Dialysis Outcomes and Practice Patterns Study
|
|
60.
|
2020
|
|
Pre-dialysis Hyponatremia and Change in Serum Sodium Concentration During a Dialysis Session Are Significant Predictors of Mortality in Patients Undergoing Hemodialysis.
|
|
61.
|
2020
|
|
Relationships between Smoking Status, Cardiovascular Risk Factors, and Lipoproteins in a Large Japanese Population.
|
|
62.
|
2020
|
|
The Normalized Protein Catabolic Rate and Mortality Risk of Patients on Hemodialysis by Frailty Status: The Japanese Dialysis Outcomes and Practice Pattern Study
|
|
63.
|
2019/11/28
|
|
Increased plasma plasmin-α2-plasmin inhibitor complex levels correlate with postoperative rebleeding after endoscopic surgery for spontaneous intracerebral hemorrhage.
|
|
64.
|
2019/10/16
|
|
Impact of Bladder Neck Involvement on Recurrence in Patients With Non-muscle-invasive Bladder Cancer: An Analysis Based on a Time-dependent Model.
|
|
65.
|
2019/10
|
|
Lipoprotein Subfractions and Glucose Homeostasis in Prediabetes and Diabetes in Taiwan.
|
|
66.
|
2019/08
|
|
Potential Impact on Lipoprotein Subfractions in Type 2 Diabetes.
|
|
67.
|
2019/07
|
|
Are SGLT2 inhibitors a targeted treatment for diabetic kidney disease?
|
|
68.
|
2019/07
|
|
Evaluation of Glomerular Hemodynamic Function by Empagliflozin in Diabetic Mice Using In Vivo Imaging.
|
|
69.
|
2019/05/30
|
|
Hyperkalemia in Real-World Patients Under Continuous Medical Care in Japan.
|
|
70.
|
2019/01
|
|
Essential points from Evidence-based Clinical Practice Guidelines for Chronic Kidney Disease 2018.
|
|
71.
|
2019
|
|
A new nutritional risk index for predicting mortality in hemodialysis patients: Nationwide cohort study.
|
|
72.
|
2019
|
|
Identifying progressive CKD from healthy population using Bayesian network and artificial intelligence: A worksite-based cohort study.
|
|
73.
|
2019
|
|
Relationship between Coombs-positive autoimmune hemolytic anemia and development of malignant tumors: a retrospective study
|
|
74.
|
2019
|
|
Use of vasopressor for dialysis-related hypotension is a risk factor for death in hemodialysis patients: Nationwide cohort study.
|
|
75.
|
2018/12
|
|
Guidelines for clinical evaluation of chronic kidney disease : AMED research on regulatory science of pharmaceuticals and medical devices.
|
|
76.
|
2018/11
|
|
Kikuchi H, Kanda E, Mori T, Sato H, Iimori S, Nomura N, Naito S, Sohara E, Okado T, Uchida S, Fushimi K, Rai T.
|
|
77.
|
2018/11
|
|
Patterns of adenoid and tonsil growth in Japanese children and adolescents: A longitudinal study
|
|
78.
|
2018/10
|
|
Dialysate Calcium Concentration below 3.0 mEq/L Is Not Associated with Improved Outcomes in the Japanese Dialysis Outcomes and Practice Patterns Study.
|
|
79.
|
2018/09
|
|
Observation period for changes in proteinuria and risk prediction of end-stage renal disease in general population.
|
|
80.
|
2018/07
|
|
SARCOPENIA AND FRAILTY IN PD: IMPACT ON MORTALITY, MALNUTRITION, AND INFLAMMATION.
|
|
81.
|
2018/07
|
|
The effect of small dose of topiroxostat on serum uric acid in patients receiving hemodialysis.
|
|
82.
|
2018/04
|
|
Importance of glomerular filtration rate change as surrogate endpoint for the future incidence of end-stage renal disease in general Japanese population: community-based cohort study.
|
|
83.
|
2018/04
|
|
Interventional nephrology: current status and clinical impact in Japan.
|
|
84.
|
2018/04
|
|
Low white blood cell count is independently associated with chronic kidney disease progression in the elderly: the CKD-ROUTE study.
|
|
85.
|
2018/03
|
|
Dapagliflozin improves treatment satisfaction in overweight patients with type 2 diabetes mellitus: a patient reported outcome study (PRO study).
|
|
86.
|
2018/03
|
|
Unexpected association between subclinical hearing loss and restorative sleep in a middle-aged and elderly Japanese population.
|
|
87.
|
2017/12
|
|
Association of the Clinical and Genetic Factors With Superior Vena Cava Arrhythmogenicity in Atrial Fibrillation.
|
|
88.
|
2017/12
|
|
Comparison of accuracy between pre-hemodialysis and post-hemodialysis levels of nutritional factors for prediction of mortality in hemodialysis patients.
|
|
89.
|
2017/09
|
|
Factors associated with posttraumatic growth among parents of children with cancer.
|
|
90.
|
2017/08
|
|
Differential changes in the adenoids and tonsils in Japanese children and teenagers: a cross-sectional study.
|
|
91.
|
2017/07
|
|
Effectiveness of dapagliflozin on vascular endothelial function and glycemic control in patients with early-stage type 2 diabetes mellitus: DEFENCE study.
|
|
92.
|
2017/06
|
|
The use of vitamin D analogs is independently associated with the favorable renal prognosis in chronic kidney disease stages 4-5: the CKD-ROUTE study.
|
|
93.
|
2017/05
|
|
Linagliptin improves endothelial function in patients with type 2 diabetes: A randomized study of linagliptin effectiveness on endothelial function.
|
|
94.
|
2017/03
|
|
Optimization of left adrenal vein sampling in primary aldosteronism: Coping with asymmetrical cortisol secretion.
|
|
95.
|
2017/02
|
|
Association of serum chloride level with mortality and cardiovascular events in chronic kidney disease: the CKD-ROUTE study.
|
|
96.
|
2017/02
|
|
Combination of low body mass index and serum albumin level is associated with chronic kidney disease progression: the chronic kidney disease-research of outcomes in treatment and epidemiology (CKD-ROUTE) study.
|
|
97.
|
2017/02
|
|
Mortality, Hospitalization, and Quality of Life among Patients with Hepatitis C Infection on Hemodialysis.
|
|
98.
|
2016/11
|
|
Association of High-Density Lipoprotein Subclasses with Chronic Kidney Disease Progression, Atherosclerosis, and Klotho.
|
|
99.
|
2016/08
|
|
Prevalent hyperglycemia in older obese population and age-dependent convergence of obese indices: Results of a cross-sectional study of Japanese generations over the adult life span.
|
|
100.
|
2016/04
|
|
Estimation of daily protein intake based on spot urine urea nitrogen concentration in chronic kidney disease patients.
|
|
101.
|
2016/01
|
|
Latent association between low urine pH and low body weight in an apparently healthy population.
|
|
102.
|
2016/01
|
|
The association of serum sodium and chloride levels with blood pressure and estimated glomerular filtration rate.
|
|
103.
|
2015/11
|
|
Effects of Weight Loss Speed on Kidney Function Differ Depending on Body Mass Index in Nondiabetic Healthy People: A Prospective Cohort.
|
|
104.
|
2015/11
|
|
Two Cases of Hemodialysis-associated Chronic Portal-systemic Shunt Encephalopathy (CPSE) with Opposite Changes in the Blood Ammonia Concentrations during Hemodialysis: A Case Report and Literature Review
|
|
105.
|
2015/09
|
|
A comparison of glycated albumin and glycosylated hemoglobin for the screening of diabetes mellitus in Taiwan
|
|
106.
|
2015/09
|
|
Use of big data in medicine.
|
|
107.
|
2015/08
|
|
Alcohol and Exercise Affect Declining Kidney Function in Healthy Males Regardless of Obesity: A Prospective Cohort Study.
|
|
108.
|
2015/06
|
|
Importance of simultaneous evaluation of multiple risk factors for hemodialysis patients' mortality and development of a novel index: dialysis outcomes and practice patterns study.
|
|
109.
|
2015/02
|
|
Uric acid level has a U-shaped association with loss of kidney function in healthy people: a prospective cohort study.
|
|
110.
|
2014/04
|
|
Decreased mobility after starting dialysis is an independent risk factor for short-term mortality after initiation of dialysis.
|
|
111.
|
2014/04
|
|
Subclinical hearing loss, longer sleep duration, and cardiometabolic risk factors in Japanese general population.
|
|
112.
|
2014/03
|
|
Causes of fever in dialysis patients and its treatment
|
|
113.
|
2014/03
|
|
Effects of sleepiness on survival in Japanese hemodialysis patients: J-DOPPS study.
|
|
114.
|
2014/02
|
|
Dietary acid intake and kidney disease progression in the elderly.
|
|
115.
|
2013/10
|
|
Relationship between Icodextrin use and decreased level of small low-density lipoprotein cholesterol fractioned by high-performance gel permeation chromatography.
|
|
116.
|
2013/10
|
|
The association of very-low-density lipoprotein with ankle-brachial index in peritoneal dialysis patients with controlled serum low-density lipoprotein cholesterol level.
|
|
117.
|
2013/07
|
|
Baseline characteristics and prevalence of cardiovascular disease in newly visiting or referred chronic kidney disease patients to nephrology centers in Japan: a prospective cohort study.
|
|
118.
|
2013/06
|
|
Anti-centromere antibody is an independent risk factor for chronic kidney disease in patients with primary biliary cirrhosis.
|
|
119.
|
2013/06
|
|
Dyslipidaemia in patients with chronic kidney disease and treatment
|
|
120.
|
2013/03
|
|
Form CMS-2728 data versus erythropoietin claims data: implications for quality of care studies.
|
|
121.
|
2013/01
|
|
High serum bicarbonate level within the normal range prevents the progression of chronic kidney disease in elderly chronic kidney disease patients.
|
|
122.
|
2012/09
|
|
Applicability of fibroblast growth factor 23 for evaluation of risk of vertebral fracture and chronic kidney disease-mineral bone disease in elderly chronic kidney disease patients.
|
|
123.
|
2011/05
|
|
Hemodialysis treatment center early mortality rates for incident hemodialysis patients are associated with the quality of care prior to starting but not following onset of dialysis.
|
|
124.
|
2008/08
|
|
Reciprocal interaction with G-actin and tropomyosin is essential for aquaporin-2 trafficking.
|
|
125.
|
2008/04
|
|
A familial case of mitochondrial disease resembling Alport syndrome.
|
|
126.
|
2007/10
|
|
A case report of thrombotic thrombocytopenic purpura and severe acute renal failure post non-myeloablative allogeneic peripheral blood stem cell transplantation treated with plasma exchange and hemodialysis.
|
|
127.
|
2007/07
|
|
Progression of Kidney Failure in Patients with Non-diabetic Chronic Kidney Disease under Combination Therapy in Japan
|
|
128.
|
2007/01
|
|
Fulminant pneumatosis intestinalis in a patient with diabetes mellitus and minimal change nephrotic syndrome.
|
|
129.
|
2005/06
|
|
Tuberous sclerosis, associated with renal cell carcinoma and angiomyolipoma, in a patient who developed endstage renal failure after nephrectomy.
|
|
130.
|
2004/12
|
|
A female patient with malarial nephropathy.
|
|
131.
|
2004/12
|
|
Role of cytokines in anaphylactoid reaction with marked eosinophilia in a hemodialysis patient.
|
|
132.
|
2003/02
|
|
Activation of Rac and tyrosine phosphorylation of cytokine receptors induced by cross-linking of integrin alpha4beta1 and cell adhesion in hematopoietic cells.
|
|
133.
|
2002/04
|
|
Rac is activated by erythropoietin or interleukin-3 and is involved in activation of the Erk signaling pathway.
|
|
134.
|
2001/08
|
|
CrkL is recruited through its SH2 domain to the erythropoietin receptor and plays a role in Lyn-mediated receptor signaling.
|
|
135.
|
2001/07
|
|
Rac is activated by tumor necrosis factor alpha and is involved in activation of Erk.
|
|
136.
|
2001/03
|
|
Rap1 is activated by erythropoietin or interleukin-3 and is involved in regulation of beta1 integrin-mediated hematopoietic cell adhesion.
|
|
137.
|
2001/01
|
|
IgA nephropathy with complement deficiency
|
|
Display 5 items
|
|
Display all(137)
|
